相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Induction of tumor-specific T-cell responses by vaccination with tumor lysate-loaded dendritic cells in colorectal cancer patients with carcinoembryonic-antigen positive tumors
Ayala Tamir et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
From cancer immunosurveillance to cancer immunotherapy
John Stagg et al.
IMMUNOLOGICAL REVIEWS (2007)
Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival
Dirk Nagorsen et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2007)
The T-box transcription factor eomesodermin controls CD8 T cell activity and lymph node metastasis in human colorectal cancer
Imke Atreya et al.
GUT (2007)
Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response
Keiichi Koizumi et al.
CANCER SCIENCE (2007)
Immunotherapy of murine colon cancer using receptor tyrosine kinase EphA2-derived peptide-pulsed dendritic cell Vaccines
Shinjiro Yamaguchi et al.
CANCER (2007)
Dendritic-cell immunotherapy:: from ex vivo loading to in vivo targeting
Paul J. Tacken et al.
NATURE REVIEWS IMMUNOLOGY (2007)
High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer
Shozo Hojo et al.
CANCER RESEARCH (2007)
High macrophage infiltration along the tumor front correlates with improved survival in colon cancer
Johan Forssell et al.
CLINICAL CANCER RESEARCH (2007)
Metastatic colorectal cancer - Current systemic treatment options
Ruth E. Board et al.
DRUGS (2007)
CD4+ CD25+ FOXP3+ Regulatory T Cells Suppress Anti-Tumor Immune Responses in Patients with Colorectal Cancer
Sarah L. Clarke et al.
PLOS ONE (2006)
In situ analysis of FOXP3+ regulatory T cells in human colorectal cancer
Christoph Loddenkemper et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2006)
Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF - Secreting cancer immunotherapy
Betty Li et al.
CLINICAL CANCER RESEARCH (2006)
Cancer despite immunosurveillance: immunoselection and immunosubversion
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Novel approaches using natural killer cells in cancer therapy
Garnet Suck
SEMINARS IN CANCER BIOLOGY (2006)
Type, density, and location of immune cells within human colorectal tumors predict clinical outcome
Jerom Galon et al.
SCIENCE (2006)
Recombinant chimeric antibody hCAb as a novel anti-human colorectal carcinoma agent
Hua Xiong et al.
MOLECULAR MEDICINE (2006)
Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world
Farin Kamangar et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Regulatory T cells, tumour immunity and immunotherapy
WP Zou
NATURE REVIEWS IMMUNOLOGY (2006)
Induction of cellular immune responses against carcinoembryonic antigen in patients with metastatic tumors after vaccination with altered peptide ligand-loaded dendritic cells
J Babatz et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Preoperative granulocyte/macrophage colony-stimulating factor (GM-CSF) increases hepatic dendritic cell numbers and clustering with lymphocytes in colorectal cancer patients
Steven J. Oosterling et al.
IMMUNOBIOLOGY (2006)
Effector memory T cells, early metastasis, and survival in colorectal cancer
F Pagès et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin
AM Intlekofer et al.
NATURE IMMUNOLOGY (2005)
Chemokines: Key players in innate and adaptive immunity
C Esche et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Intratumoral injection of immature dendritic cells enhances antitumor effect of hyperthermia using magnetic nanoparticles
K Tanaka et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Towards therapeutic vaccines for colorectal carcinoma: a review of clinical trials
Szilvia Mosolits et al.
EXPERT REVIEW OF VACCINES (2005)
Natural killer and NK-Like T-Cell activation in colorectal carcinoma patients treated with autologous tumor-derived heat shock protein 96
L Pilla et al.
CANCER RESEARCH (2005)
Prognostic value of tumor-infiltrating dendritic cells in colorectal cancer: Role of maturation status and intratumoral localization
MH Sandel et al.
CLINICAL CANCER RESEARCH (2005)
Dendritic cells as therapeutic vaccines against cancer
J Banchereau et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Cancer incidence and mortality in Europe, 2004
P Boyle et al.
ANNALS OF ONCOLOGY (2005)
Dendritic cells and vascular endothelial growth factor in colorectal cancer: Correlations with clinicobiological findings
M Della Porta et al.
ONCOLOGY (2005)
Use of cytokines in cancer vaccines/immunotherapy: Recent developments improve survival rates for patients with metastatic malignancy
S Dezfouli et al.
CURRENT PHARMACEUTICAL DESIGN (2005)
Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis
A Gardini et al.
JOURNAL OF SURGICAL ONCOLOGY (2004)
Colorectal cancer vaccines: Principles, results, and perspectives
S Mocellin et al.
GASTROENTEROLOGY (2004)
Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells:: a clinical phase I trial
SW Krause et al.
CLINICAL CANCER RESEARCH (2004)
Dendritic cells in colorectal cancer correlate with other tumor-infiltrating immune cells
AR Dadabayev et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Colorectal cancers with microsatellite instability display mRNA expression signatures characteristic of increased immunogenicity
Ayan Banerjea et al.
MOLECULAR CANCER (2004)
Control of effector CD8+ T cell function by the transcription factor Eomesodermin
EL Pearce et al.
SCIENCE (2003)
Follow-up of patients with curatively resected colorectal cancer: a practice guideline
A Figueredo et al.
BMC CANCER (2003)
Natural killer (NK) cell function is a strong prognostic factor in colorectal carcinoma patients treated with the monoclonal antibody 17-1A
M Liljefors et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
EpCAM - A new therapeutic target for an old cancer antigen
A Armstrong et al.
CANCER BIOLOGY & THERAPY (2003)
MHC class I antigens, immune surveillance, and tumor immune escape
A Garcia-Lora et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2003)
Immunology and immunotherapy of colorectal cancer
P Dalerba et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2003)
Vascular endothelial growth factor, CD68, and epidermal growth factor receptor expression and survival in patients with stage II and stage III colon carcinoma - A role for the host response in prognosis
AA Khorana et al.
CANCER (2003)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
Immunity to cancer: attack and escape in T lymphocyte-tumor cell interaction
L Rivoltini et al.
IMMUNOLOGICAL REVIEWS (2002)
Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study
CJA Punt et al.
LANCET (2002)
The role of CD8+ T cells in immune responses to colorectal cancer
LV Titu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2002)
Mature dendritic cells make clusters with T cells in the invasive margin of colorectal carcinoma
A Suzuki et al.
JOURNAL OF PATHOLOGY (2002)
The biology of human natural killer-cell subsets
MA Cooper et al.
TRENDS IN IMMUNOLOGY (2001)
Natural killer cells, viruses and cancer
A Cerwenka et al.
NATURE REVIEWS IMMUNOLOGY (2001)
Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy
L Fong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
V Shankaran et al.
NATURE (2001)
Tumour infiltrating lymphocytes and apoptosis are independent features in colorectal cancer stratified according to microsatellite instability status
JM Michael-Robinson et al.
GUT (2001)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
Monoclonal antibody therapy for solid tumors
MC Green et al.
CANCER TREATMENT REVIEWS (2000)
Prognostic significance of extensive microsatellite instability in sporadic clinicopathological stage C colorectal cancer
CM Wright et al.
BRITISH JOURNAL OF SURGERY (2000)
分享论文
